Dr. Codding is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1211 North Shartel Avenue
Suite 700
Oklahoma City, OK 73103Phone+1 405-702-6700Fax+1 405-702-6720
Education & Training
University of Oklahoma Health Sciences CenterFellowship, Rheumatology, 1989 - 1991- University of Oklahoma Health Sciences CenterResidency, Internal Medicine, 1986 - 1989
- University of Oklahoma College of MedicineClass of 1986
Certifications & Licensure
OK State Medical License 1987 - 2025
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor Start of enrollment: 2013 Jul 01
- An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2013 Jun 27
- Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2012 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 224 citationsEffect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled studyIain B. McInnes, Liz Thompson, Jon T. Giles, Joan M. Bathon, Jane E. Salmon
Annals of the Rheumatic Diseases. 2015-04-01 - 133 citationsSecukinumab in Active Rheumatoid Arthritis: A Phase III Randomized, Double-Blind, Active Comparator- and Placebo-Controlled Study.Francisco J. Blanco, Rüdiger Möricke, Eva Dokoupilova, Christine E Codding, Jeffrey Neal
Arthritis & Rheumatology. 2017-06-01 - 220 citationsEfficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled studyMark C. Genovese, Patrick Durez, Hanno B. Richards, Jerzy Supronik, Eva Dokoupilova
Annals of the Rheumatic Diseases. 2013-06-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
